Company intelligence / Profile preview
Genomma Lab
- Ownership
- Private
- Employees
- ~1665
- Development stage
- Other
Overview
Genomma Lab operates primarily in the consumer health and OTC pharmaceutical sectors; its products—including several market-leading brands for pain relief, GI, dermal, and beauty care—are commercially available across Latin America, the US, and other markets, with no clinical pipeline typical of a biotech or pharma development-stage company.
- Therapeutic areas
- RheumatologyInfectious DiseasesGastroenterologyDermatologyCardiovascularNeurology
- Modalities
- Small moleculetopicalbeverage
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Genomma Lab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genomma Lab.